Private · Company · Aksjeselskap
Prophylix Pharma Holding AS
↳ Brreg · companies
Employees—
CEO · since—
Chair · sinceKarl Johan Jakola 2026-06
BOARD · 3 ROLES
Roles from Brreg, shown for business contact only. No birth date is shown or exported (purpose limitation, GDPR Art. 6(1)(f)).
Brreg · company_people
Group revenue
—
Group net
kr -2.44M
Tenders won
0
Rolled up across the parent + 1 subsidiary — Prophylix AS alone is —.
rollup estimate · filed konsernregnskap not yet in Intelligo
company
| 2024 | 2025 | ||
|---|---|---|---|
| Revenue | |||
| Operating result | kr -71k | kr -71k | |
| Net result | kr -2.32M |
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | ||
|---|---|---|---|---|---|---|---|
| Revenue | |||||||
| Operating result | kr -71k | kr -71k | |||||
| Net result | kr -2.32M |
Total assets kr 44kEquity kr -156k
Regnskapsregisteret · rollup across ownership edges (estimate)
accounts_filed: sisteInnsendteAarsregnskap2024 -> 2025Registry · 2026-07-09
| 2024 | 2025 | ||
|---|---|---|---|
| NORINNOVA INVEST AS | 11 | 11 | — |
| SARSIA SEED AS | 6 | 6 | — |
| TROND MOHN FORSKNINGSSTIFTELSE | 16 | 16 | — |
| NORINNOVA AS | 5 | 5 | — |
| UNIVERSITETSSYKEHUSET NORD-NORGE HF | 5 | 5 | — |
| KRAKR AS | 2 | 2 | — |
| CAERUS CAPITAL AS | 1 | 1 | — |
| INVEN2 AS | 1 | 1 | — |
| PHARMAPATENT AS | 0 | 0 | — |
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | ||
|---|---|---|---|---|---|---|---|
| NORINNOVA INVEST AS | 31 | 11 | 11 | 11 | 11 | 11 | — |
| SARSIA SEED AS | 19 | 6 | 6 | 6 | 6 | 6 | — |
| TROND MOHN FORSKNINGSSTIFTELSE | 16 | 16 | 16 | 16 | 16 | 16 | — |
| NORINNOVA AS | 9 | 5 | 5 | 5 | 5 | 5 | — |
| UNIVERSITETSSYKEHUSET NORD-NORGE HF | 6 | 5 | 5 | 5 | 5 | 5 | — |
| KRAKR AS | 2 | 2 | 2 | 2 | 2 | 2 | — |
| CAERUS CAPITAL AS | 1 | 1 | 1 | 1 | 1 | 1 | — |
| INVEN2 AS | 1 | 1 | 1 | 1 | 1 | 1 | — |
| PHARMAPATENT AS | 0 | 0 | 0 | 0 | 0 | 0 | — |
Aksjonærregisteret · company_ownership · 2025 · both directions
| 2024 | 2025 | 2026 | |
|---|---|---|---|
| auditor — | |||
| accountant FETT ØKONOMI AS 2026-06-23 | ● |
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | |
|---|---|---|---|---|---|---|---|
| auditor — | |||||||
| accountant FETT ØKONOMI AS 2026-06-23 | ● |
Brreg · company_org_roles
No recorded tender wins.
Relevant open tenders — matched NACE 21.200 ↔ CPV
subscribers sharpen matches with per-company keywords
open-tender matching (NACE ↔ CPV) awaits Intelligo's open-tenders view
Doffin/TED · company_tender_wins · 2026-08-14
No job ads on record in the last 12 months.
NAV Arbeidsplassen · company_job_ad_months
Owns ↓ · 1 subsidiary
From the annual report
This company's annual report has not been read yet. The filed figures above come from the accounts form; everything the board wrote around them is in the PDF, which is read on request.
Regnskapsregisteret (årsberetning) · company_annual_reports
From the FY2025 accounts
FILEDAccounts filed for FY2025.
AUDITOpted out of audit (fravalg) on 30 Jul 2025.
GROUPFiles as a parent with 1 subsidiaries.
BALANCEEquity kr -156k.
Regnskapsregisteret + Brreg roles · the filed accounts form. What the board wrote around the figures is in the annual report block.
registered 2017-12-11audit opt-out 2025-07-30
Brreg · companies
accounts_filed: sisteInnsendteAarsregnskap2024 -> 2025Registry · 2026-07-09
liquidation: underAvviklingFalse -> TrueRegistry · 2026-06-19
Skiwo · company_events